This resolution (S. Res. 374) is a formal expression by a group of senators that Secretary of Health and Human Services Robert F.
Kennedy Jr. ‘‘does not have the confidence of the Senate or of the American people’’ and therefore should be removed from office. The text lays out a long list of findings alleging misconduct: an anti‑vaccine agenda, abrupt terminations of grants and staff, reorganization steps said to exceed statutory authority, and actions that undermine core HHS programs.
Although the resolution does not itself remove or discipline the Secretary, it packages specific factual allegations and statutory citations into a single Senate statement. That makes it a tool for political pressure, oversight, and coordination with ongoing litigation and agency reviews — and it signals to federal agencies, states, and courts how a significant bloc of senators views HHS leadership and department stability.
At a Glance
What It Does
S. Res. 374 is a sense‑of‑the‑Senate resolution that states the Senate lacks confidence in the HHS Secretary and recommends his removal. The only operative language is a nonbinding declaration; the bulk of the document is an extensive preamble listing factual findings and statutory citations.
Who It Affects
The resolution targets the Secretary and his leadership decisions but also implicates HHS career staff, federal research institutions, state public‑health programs, and parties to ongoing lawsuits against HHS. It is primarily a political and oversight instrument rather than a legal sanction.
Why It Matters
By consolidating allegations about grant cancellations, workforce reductions, advisory‑committee purges, and statutory violations, the resolution amplifies congressional scrutiny and supports intervening states and research groups in litigation or oversight. For regulators, grant recipients, and compliance officers, the resolution signals potential reversals, oversight hearings, and heightened legal risk around HHS program decisions.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
S. Res. 374 contains one short operative clause — a declaration that the Secretary lacks the Senate’s confidence and should be removed — and a long preamble that itemizes alleged misconduct.
The preamble alleges that the Secretary pursued an ‘‘anti‑science and anti‑vaccine’’ agenda, used reorganizations and reductions‑in‑force to push out scientists and career staff, and curtailed functions and offices congressionally mandated to address minority health, aging, and disability services.
The resolution cites concrete actions as the basis for those findings: the Department’s sudden termination of approximately $11 billion in public‑health funding on March 24, 2025; the issuance of termination notices to roughly 5,200 probationary employees within days of the Secretary’s swearing‑in; public announcements to remove up to 20,000 federal civil servants from health agencies; and the elimination or crippling of offices such as the Offices of Minority Health. It details a series of NIH grant terminations described internally as no longer ‘‘effectuat[ing] agency priorities,’’ pauses and cancellations of clinical trials, and the rescission of a notice‑and‑comment commitment known informally as the ‘‘Richardson Waiver.’nThe preamble also focuses on advisory and regulatory disruptions: the Secretary’s removal of all 17 members of the Advisory Committee on Immunization Practices and replacement with fewer appointees some senators describe as vaccine skeptics; the cancellation of numerous mRNA vaccine projects; and high‑profile departures and firings at CDC and FDA leadership.
The text cites litigation brought by multiple states and national research organizations alleging violations of the Administrative Procedure Act, the Appropriations Clause, and other statutory duties.Taken as a whole, the resolution does not change statutes or compel executive action; instead it collects factual assertions, statutory references (including sections of the Public Health Service Act and the Administrative Procedure Act), and litigation developments into a single Senate statement intended to increase political pressure and coordinate congressional oversight and legal remedies.
The Five Things You Need to Know
S. Res. 374 is a non‑binding, sense‑of‑the‑Senate resolution whose sole operative sentence declares the Secretary lacks confidence and should be removed.
The preamble identifies a March 24, 2025 action in which HHS abruptly terminated roughly $11 billion in public‑health funding to states, tying that action to programmatic and surveillance risks.
The resolution documents rapid workforce cuts: about 5,200 probationary workers received termination notices days after the Secretary’s swearing‑in, and HHS announced plans that could push out as many as 20,000 federal health employees.
S. Res. 374 details the wholesale replacement of the Advisory Committee on Immunization Practices — all 17 members removed and later replaced by a smaller, handpicked panel — and connects that change to proposed revisits of the childhood vaccine schedule.
The text cites coordinated litigation: 23 states have sued the Secretary and HHS, while national research organizations and scientists have brought APA challenges over grant terminations and alleged departures from statutory NIH duties.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Enumerated findings alleging statutory breaches and program harm
The preamble is a long catalog of factual allegations the sponsors say justify censuring the Secretary. It identifies specific statutes (for example, multiple provisions of the Public Health Service Act, the Older Americans Act, and the Rehabilitation Act) the sponsors say HHS leadership has violated. Practically, the findings compile chronology, agency actions, and program impacts that senators can use when framing oversight requests, subpoenas, or public messaging.
Alleged arbitrary terminations of NIH grants and clinical trials
This section of the preamble focuses on NIH and NIH‑funded research: sponsors describe hundreds of grants paused or terminated, clinical trials delayed or ended, and specific programmatic areas affected (Alzheimer’s, maternal health disparities, HIV prevention, mRNA vaccine work). For institutions and investigators, these findings flag both reputational and practical disruptions — interrupted studies, lost funding, and potential contract or grant‑related litigation risks.
Alleged mass reduction in force and elimination of offices
The resolution documents multiple waves of personnel actions: initial termination notices to probationary employees, an announced push to remove up to 20,000 staff, and the elimination or defanging of units such as Offices of Minority Health and elements of CDC and ACL. From a compliance standpoint, sponsors claim many of these moves exceeded statutory authority or appropriations constraints, which is central to several lawsuits referenced in the preamble.
Alleged politicization of vaccine policy and advisory bodies
Sponsors single out the Secretary’s handling of vaccines: cancelling ACIP meetings, removing all 17 ACIP members and appointing a smaller roster including vaccine skeptics, withdrawing certain vaccine recommendations for pregnant women and children, and cancelling mRNA‑related projects. They argue these steps undermine scientific consensus and threaten immunization programs and disease control efforts.
Sense of the Senate: declaration urging removal
The resolution’s only operative text is a statement of sentiment — it declares the Secretary lacks the confidence of the Senate and should be removed. That language is purely declaratory; it does not create legal consequences, remove the Secretary, or direct the President. Its value is political and evidentiary: it formalizes Senate condemnation and can be cited in oversight, appropriation decisions, or by litigants seeking a congressional position on HHS conduct.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Senators and oversight committees sponsoring the resolution — they gain a consolidated, Senate‑level statement they can use to justify hearings, subpoena requests, or budget scrutiny.
- States and research organizations suing HHS — the resolution’s factual findings bolster political support for their litigation and may influence public perception and court filings.
- Public‑health advocacy groups and vaccine proponents — a high‑visibility Senate statement adds pressure for HHS to restore programs and staff argued to be essential for disease prevention and equity.
- Career civil servants and affected grantees seeking restoration or redress — the resolution increases leverage for reversals, rehiring, or settlements by documenting congressional concern.
Who Bears the Cost
- The Secretary and his political supporters — the resolution concentrates political opposition and increases pressure for resignation, removal by the President, or intensified scrutiny.
- HHS leadership and agency operations — the heightened scrutiny risks short‑term instability, slows decisionmaking, and could complicate ongoing program transitions and litigation posture.
- Communities served by disrupted programs — interruptions to surveillance, immunization, maternal health, aging, and disability services can translate into real service gaps and delayed research outcomes.
- Federal employees and contractors not targeted by firings — morale and retention may deteriorate across HHS as politicization and public controversy intensify, increasing operational costs and turnover.
Key Issues
The Core Tension
The central dilemma is accountability versus operational stability: the Senate can and arguably should call out conduct that violates statutory duties, yet a symbolic condemnation that does not change the legal relationship between the executive and legislative branches may increase turmoil at an agency whose effective functioning is vital to public health.
The resolution is powerful rhetorically but legally toothless. It does not vacate an appointment, trigger removal procedures, or change statutory responsibilities; removal of an executive‑branch Secretary requires presidential action, impeachment and conviction, or voluntary resignation.
The document’s primary utilities are political: it aggregates allegations into a single Senate posture, increases pressure on the White House, and supplies a public record useful to litigants and oversight processes.
That political utility creates tradeoffs. Elevating a nonbinding denunciation can shore up oversight and create momentum for corrective action, but it also risks deepening administrative instability at an agency responsible for pandemic preparedness, immunizations, and safety‑critical research.
Courts weighing APA claims will treat the resolution as political speech, not dispositive legal authority, although its factual recitals may influence public perceptions and the tone of subsequent congressional investigations. Implementation risks include further staff departures, complications in grant‑making and regulatory processes, and the potential for rhetoric to exacerbate public distrust of health institutions at a time when continuity matters most.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.